Implementation Guide CH VACD
6.0.0 - trial-use Switzerland flag

This page is part of the CH VACD (R4) (v6.0.0: STU 6) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

Example Immunization: TCF1 Immunization 2

Author of the content: Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number)

CH VACD Extension Immunization Medication Reference: Medication HAVRIX 1440 Inj Susp

CH VACD Extension verificationStatus: SNOMED CT: 76104008 (Not confirmed)

Entry Resource Cross References

  • entry: Identifier: urn:oid:2.999.1.2.3.4/855bdd69-0a39-4241-b208-9b248a62fb76
  • container: Identifier: Uniform Resource Identifier (URI)/urn:uuid:e2233a2f-d1c2-459d-b4fe-4920c35339e7
  • relationcode: replaces

identifier: urn:oid:2.999.1.2.3.4/e2233a2f-d1c2-459d-b4fe-4920c35339e7

status: Completed

vaccineCode: Havrix 1440

patient: Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number)

occurrence: 2021-05-27

recorded: 2021-05-27 00:00:00+0200

lotNumber: AHAVB946A

route: Intramuscular use

Performers

-Actor
*PractitionerRole

note: By Practitioner/TC-HCP1-C1 @2021-06-02

Der Patient hat diese Impfung ohne jegliche Nebenwirkungen gut vertragen.

ProtocolApplieds

-TargetDiseaseDoseNumber[x]
*Viral hepatitis, type A (disorder)1